This paper addresses how biopharmaceutical companies are turning to strategic outsourcing to address their business needs because these partnerships lower the cost of doing business, while increasing productivity and efficiency.
How Digital Medicine Can Pinpoint Dosing Regimens to Optimize Drug Efficacy and Safety
Sponsored By Oracle
Multi-faceted Approaches to Meet Payer and Regulatory Evidence Requirements
Sponsored By UBC Express Scripts
Overcoming the Life Sciences Content Conundrum in a Multichannel World
Sponsored By Veeva